Sep 20, 2024, 14:47 | Blog

That’s a wrap on ESMO2024 - Agenus

Agenus shared a post on LinkedIn: "That’s a wrap on ESMO2024. Our team had a great…

Sep 20, 2024, 14:38 | Blog

Tracey O'Brien: Cancer Institute NSW will host the Inaugural NSW Cancer Summit next year

Tracey O'Brien shared a post on LinkedIn: "I’m excited to share the news that next year,…

Sep 20, 2024, 14:01 | Blog

Zainab Shinkafi-Bagudu: Gathering advocates to discuss Cervical Cancer at WHO HQ

Zainab Shinkafi-Bagudu posted the following on LinkedIn: “At the WHA 77 in May 2024, a…

Sep 20, 2024, 13:15 | Blog

Grand Rounds on Nutrition in Oncology - IOWG

Integrative Oncology Working Group posted the following on LinkedIn: “IOWG is honored to host Geeta…

Sep 20, 2024, 12:37 | Insight

Saarang Deshpande: Frontline caplacizumab and plasma exchange in TTP

Saarang Deshpande shared a post on X: "Thread on frontline caplacizumab and plasma exchange in…

Sep 20, 2024, 12:32 | Blog

Mark Lawler: Financial discrimination against cancer survivors

Mark Lawler, Chair in Translational Cancer Genomics at Queen's University Belfast, shared a post on…

Sep 19, 2024, 19:07 | Blog

Babar Gulzar: I am applying for the Radiation Oncology Match 2025

Babar Gulzar, Radiation Oncology Clinical Observer, UPMC, shared a post on X: "Hello everyone! I…

Sep 19, 2024, 18:59 | Insight

Vivek Subbiah about “Tumor-Agnostic Biomarker Driven Drug development" at ASCO and ESMO joint session

Vivek Subbiah shared a post on LinkedIn: "It was such a great honor to talk…

Sep 19, 2024, 18:53 | Insight

Thorvardur Halfdanarson: Cabozantinib in previously treated advanced NETs

Thorvardur Halfdanarson, Professor of Oncology at Mayo Clinic School of Medicine, shared a post on…

Sep 19, 2024, 18:47 | Insight

Rajat Thawani on "Combination Immunotherapy clinical trials in NSCLC"

Rajat Thawani, Assistant Professor, University of Chicago Hematology/Oncology, shared a post on X: "It was…

Sep 19, 2024, 18:41 | Blog

Jeff White: It’s hard to make yourself vulnerable again to what the machine finds

Jeff White shared a post on X: "Here we go again. Another PET. It’s hard to…

Sep 19, 2024, 18:10 | Blog

Lilin Tong: I am applying into Internal Medicine for Match 2025

Lilin Tong, M.D. Candidate at Boston University School of Medicine, shared a post on X:…

Sep 19, 2024, 15:18 | Insight

Paolo Tarantino: Monitoring ADC-related interstitial lung disease

Paolo Tarantino shared a post on LinkedIn: "More sensitive ways are needed to monitor for ADC-related…

Sep 19, 2024, 14:59 | Blog

Julie Gralow: Key Insights from ASCO at WCC2024

Julie Gralow shared a post on LinkedIn: "WCC2024 session “Key Insights from ASCO: Findings from recent…

Sep 19, 2024, 14:52 | Blog

Nirmala Bhoo Pathy: Day 1 of the World Cancer Congress was all about networking

Nirmala Bhoo Pathy shared a post on LinkedIn: "Day 1 of the World Cancer Congress…

Sep 19, 2024, 14:45 | Blog

Sarah Scagliarini: ESMO24 take home message

Sarah Scagliarini, Medical Oncologist, Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli, Italy, shared a post…

Sep 19, 2024, 13:44 | Blog

OncoInfluencers to Follow on Social Media: Dr. Maryam Lustberg

We are excited to spotlight Dr. Maryam Lustberg as a leading figure in breast cancer…

Sep 19, 2024, 07:37 | Blog

Patrizia Giannatempo: The benefit of adjuvant pembrolizumab with extended follow-up 45 months

Patrizia Giannatempo shared a post on X: "The AMBASSADOR trial confirms the benefit of adjuvant…

Sep 19, 2024, 07:25 | Blog

Cristiane D Bergerot: I'm honored to serve on the Program Committee of ASCOQLTY24

Cristiane D Bergerot shared a post on X: "Next conference: American Society of Clinical Oncology…

Sep 18, 2024, 21:59 | Blog

Kimryn Rathmell: Happy National Postdoc Appreciation Week

Kimryn Rathmell shared a post on X: "Happy National Postdoc Appreciation Week! I want to personally…

Sep 18, 2024, 17:57 | Blog

Pat Price: I believe the cancer crisis is our most pressing health emergency at present

Pat Price shared a post on LinkedIn: "I believe the cancer crisis is our most pressing…

Sep 18, 2024, 14:12 | OncoDaily Pulse

OncoDaily Forms Strategic Partnership with the National Foundation for Cancer Research (NFCR)

OncoDaily is thrilled to announce a new strategic partnership with the National Foundation for Cancer…

Sep 18, 2024, 11:58 | Blog

OncoInfluencers to Follow on Social Media: Dr. Vivek Subbiah

We are excited to highlight Dr. Vivek Subbiah as a prominent figure in the field…

Sep 18, 2024, 10:07 | Blog

Daniel Sumarriva: Discussing personalized treatments and digital oncology at ESMO24

Daniel Sumarriva, Senior Director of Molecular Science Liaisons at Caris Life Sciences, shared a post…

Sep 18, 2024, 06:29 | Insight

The overlooked issue of women's sexual health during cancer treatment

Florez Lab shared on X: “New publication alert. Our latest publication in The Oncologist Journal…

Sep 17, 2024, 19:28 | Blog

Introducing ENTERO 2024 - European Cancer Organisation

European Cancer Organisation shared a post on LinkedIn: ''Introducing ENTERO 2024! A first-of-its-kind conference to…

Sep 17, 2024, 16:17 | Blog

Paolo Tarantino: Forever grateful to mentor and friend Joey Curigliano

Paolo Tarantino posted the following on X: “Here’s to a mentor, a friend, a fierce…

Sep 17, 2024, 15:18 | Blog

Arevik Stepanyan: National Center of Oncology of Armenia team is at ESMO 2024

Arevik Stepanyan, Head of the Cancer Registry Department at the National Center of Oncology in Armenia,…

Sep 17, 2024, 15:16 | Blog

Key takeaways from ESMO24 Oral session on early stage breast cancer by Rasha Aboelhassan

Rasha Aboelhassan shared a post on LinkedIn: ''Mini oral session today. Early stage breast cancer…

Sep 17, 2024, 14:58 | Blog

Standing together to improve healthcare infrastructure - SIOP International

SIOP International shared a post on X: ''In Latin America, access to care is again…

Sep 17, 2024, 09:06 | Blog

Paolo Tarantino: Gene signatures have revolutionized treatment for HR+ eBC

Paolo Tarantino shared on X: "Gene signatures have revolutionized treatment for HR+ eBC. Could they…

Sep 17, 2024, 01:02 | Blog

Monika Pansari: Empowering women with advanced surgical approaches to breast & ovarian cancer

Monika Pansari posted the following on LinkedIn: “Dr. Monika Pansari recently delivered an insightful session…

Sep 17, 2024, 00:18 | Blog

André Gouveia: Highlighting the urgent need for improved patient access to radiotherapy in Brazil

Fabio Ynoe de Moraes shared a post by André Gouveia on LinkedIn, adding the following:…

Sep 15, 2024, 14:54 | Blog

Joshua Omale: The role of policy in childhood cancer care

Joshua Omale shared a post on LinkedIn: ''Day 13: The role of policy in childhood…

Sep 14, 2024, 17:48 | Blog

Beatrice Okumu: City Cancer Challenge's series of meetings in Nairobi

Beatrice Okumu, City Manager-Nairobi at City Cancer Challenge, posted on LinkedIn: "The City Cancer Challenge…

Sep 14, 2024, 13:44 | Blog

Luis Diaz Jr. discusses the potential of immunoablative neoadjuvant therapy at CICON24 - CRI

CRI (Cancer Research Institute) shared a post on LinkedIn: ''During the first session of CICON24,…

Sep 14, 2024, 13:33 | Blog

Avirup Guha: The impact of ADT on physical measures and cardiovascular outcomes in prostate cancer

Avirup Guha shared a post on X, about recent paper published in JACC CardioOncology: Adiposity…

Sep 14, 2024, 12:25 | Blog

Young patients with breast cancer have unique needs that must be addressed - ESMO

ESMO - European Society for Medical Oncology posted the following on LinkedIn: “Young patients with…

Sep 14, 2024, 12:19 | Blog

Long-term follow-up care remains one of the biggest challenges for childhood cancer survivors - Childhood Cancer International

Childhood Cancer International posted the following on LinkedIn: “Childhood Cancer survivors recognize long term follow-up…

Sep 14, 2024, 12:17 | Blog

OncoInfluencers to Follow on Social Media: Dr. Monica Bertagnolli

We are thrilled to spotlight Dr. Monica Bertagnolli as a significant figure in the oncology…

Sep 14, 2024, 12:15 | Blog

Amol Akhade: Polestar vs Laura – What’s your pick?

Amol Akhade posted the following on LinkedIn: “Polestar vs Laura? Third-generation TKI post CTRT for…

Sep 13, 2024, 19:31 | Blog

Paxman Scalp Cooling celebrates Dr. Ertugrul Unver’s retirement and contributions

Paxman Scalp Cooling posted the following on LinkedIn: “Last week we celebrated Dr. Ertugrul Unver’s…

Sep 13, 2024, 19:19 | Blog

Advances in cancer care must consider the impact on patients’ reproductive health - ASCO

ASCO - American Society of Clinical Oncology made the following post on LinkedIn: “Advances in cancer care…

Sep 13, 2024, 19:05 | Blog

Miriam Mutebi discusses Africa’s vulnerability in health supplies during COVID-19

Miriam Mutebi posted the following on LinkedIn: “The COVID-19 pandemic exposed Africa’s vulnerability in relying on…

Sep 13, 2024, 15:50 | Blog

Justin shares his success with a novel treatment for non-Hodgkin lymphoma - NCI Center for Cancer Research

NCI Center for Cancer Research shared the following post on LinkedIn: “Justin joined a CCR…

Sep 13, 2024, 15:46 | Blog

ACGA is grateful to have the American Cancer Society as an its member!

American Council on Gift Annuities made the following post on LinkedIn: “Member Monday: We are grateful…

Sep 13, 2024, 10:46 | Blog

Chris De Savi: Breaking News from WCLC24

Chris De Savi shared a post on LinkedIn: ''Ivonescimab Outshines Keytruda in 1st Line Lung…

Sep 13, 2024, 08:15 | Blog

Enrique Soto: Time toxicity among older patients with cancer

Enrique Soto shared a post on X, about their manuscript published in Supportive Care in…

Sep 12, 2024, 21:10 | Blog

Obstetric fistula repairs have been successfully performed for 45 women at the Dr. Amina Bello Women Health Center - Raise Foundation

Raise Foundation shared a post on X: ''Obstetric fistula repairs have been successfully performed for…

Sep 12, 2024, 20:46 | Blog

Hedley Lewis: CHOC and The Core Group launch iSchoolAfrica iPad Learning Program in Gauteng Hospital

Hedley Lewis shared a post on LinkedIn: ''CHOC and The Core Group Unite to launch…

Sep 12, 2024, 20:43 | Blog

Carmen Uscatu: Turning suffering into a character

Carmen Uscatu, Founding Member, President at Give Life (Dăruiește Viață), shared a post on LinkedIn: ''She…

Sep 12, 2024, 14:42 | Insight

Colon Cancer Treatment: NICHE-2 Validates Immunotherapy

Maria Babak shared a post by The Babak Lab on LinkedIn: “ This research highlights…

Sep 11, 2024, 19:03 | Blog

Celebrating Exceptional Lung Cancer Care Worldwide

Celebrating Exceptional Lung Cancer Care Worldwide. Outstanding lung cancer care goes beyond individual specialists or…

Sep 11, 2024, 18:57 | Blog

Congratulations to the 2024 Jen Brock Memorial Award recipient, Dr. Dinh Thi Lan Anh

Congratulations to the 2024 Jen Brock Memorial Award recipient, Dr. Dinh Thi Lan Anh! Dr.…

Sep 11, 2024, 13:54 | Blog

Noemi Reguart: Presidential Phase 3, Ivonescimab vs Pembrolizumab for PD-L1+ advanced NSCLC

Noemi Reguart shared a post on X: ''WCLC24 Presidential. Phase 3 Ivonescimab (AK112) versus Pembrolizumab…

Sep 10, 2024, 19:09 | Blog

CancerX members gathered for our annual meeting and convened with federal representatives

CancerX Moonshot posted the following on LinkedIn: “This week, representatives from the 150+ CancerX member…

Sep 10, 2024, 14:23 | Blog

Jill Feldman: Fantastic IASLC STARS Scholars get-together

Jill Feldman shared a post on X: ''Fantastic IASLC STARS Scholars get-together! We ate, drank,…

Sep 10, 2024, 13:52 | Career

Antonio Giordano: Excited to welcome Dr. Benjamin Ebert as next CEO of Dana Farber Cancer Institute

Antonio Giordano, President of Sbarro Health Research Organization, shared a post by The Boston Globe,…

Sep 10, 2024, 13:45 | Societies

Rami Manochakian's key highlights from WCLC24

WCLC is a major international event focused on the latest advancements in lung cancer research,…

Sep 10, 2024, 10:38 | Blog

Vivek Subbiah: Precision Dosing IS Precision Oncology

Vivek Subbiah shared a post on X: “Pleased to share the pre-proof version of the…

Sep 10, 2024, 10:28 | Blog

Matthew Herper: Facing cancer is hard -- even if you're someone who would change the way we treat cancer

Matthew Herper, Senior Writer, Medicine, and Editorial Director, Events at STAT, made the following post…

Sep 10, 2024, 00:19 | Blog

Miriam Mutebi: In many African cultures cancer is referred to as a 'wound with which we will be buried'

Miriam Mutebi shared a post on LinkedIn: ''In many African cultures, the language used to…

Sep 9, 2024, 13:23 | Immune Oncology,Oncolibrary

Immunotherapy vs Chemotherapy: Success Rates, Side Effects, Costs Compared

When comparing immunotherapy vs chemotherapy, it's important to understand how these cancer treatments work differently.…

Sep 9, 2024, 13:17 | Cancer Types

Small Bowel Cancer: Alarming Symptoms and Causes, Types, Diagnosis and Treatment

Small bowel cancer, often referred to as small intestine cancer, is a rare but serious…

Sep 9, 2024, 10:34 | Blog

Sami Mansfield: Empowering Cancer Survivors Through Lifestyle Changes

Sami Mansfield shared a post on LinkedIn: ''Gynecological Cancer Awareness Month. Empowering Cancer Survivors Through…

Sep 8, 2024, 05:34 | Insight

UICC’s Rewriting Cancer series exploring the experiences of those living with cancer

Union for International Cancer Control (UICC) posted on LinkedIn: “Cancer – it’s a word that…

Sep 7, 2024, 09:53 | Insight

Elie G. Dib: Precision Oncogenomics - An Open Acess Journal

Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital, posted…

Sep 7, 2024, 09:28 | Drugs

Elvina Almuradova: Doxorubicin with Trabectedin show promising results for patients with leiomyosarcoma

Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared on LinkedIn: "New findings published…

Sep 7, 2024, 09:20 | Insight

New Y-ECI CLTG and ROSC Webinar Series - EORTC

EORTC - European Organisation for Research and Treatment of Cancer shared on LinkedIn: "Save the…

Sep 7, 2024, 05:34 | Blog

Survival Outcomes in Real-World Settings After Alternative Pembrolizumab Dosing for NCSLC

Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X, about recent paper…

Sep 6, 2024, 12:35 | Blog

Olubukola Ayodele: Every breast cancer journey is unique, and seeking advice from an oncologist is vital in navigating a diagnosis

Olubukola Ayodele posted on LinkedIn: “I recently read about Elle Macpherson and her journey with breast…

Sep 5, 2024, 18:45 | Blog

Applications open for the FIGHT KIDS CANCER 2025

Fight Kids Cancer shared a post on LinkedIn: ''We look forward to receiving your applications…

Sep 5, 2024, 18:09 | Blog

How biomarkers can predict patients' responses to ICI treatments - CRI

CRI (Cancer Research Institute) shared a post on LinkedIn: ''Led by CRI Scientific Advisory Council…

Sep 5, 2024, 17:55 | Blog

Your support of Childhood Cancer Awareness Month - Conquer Cancer, the ASCO Foundation

Conquer Cancer, the ASCO Foundation shared a post on LinkedIn: ''Your support of Childhood Cancer…

Sep 5, 2024, 17:06 | Blog

Supporting upper GI cancer with medical nutrition therapy - SPCC

SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn: ''Save the date for…

Sep 5, 2024, 16:56 | Blog

Alejandra Gonzalez Ruiz: Childhood Cancer Awareness Month honors patients and survivors while raising awareness about pediatric cancer

Alejandra Gonzalez Ruiz, Senior Program Manager - Oncology Strategic Initiatives at St. Jude Children's Research…

Sep 5, 2024, 05:09 | Blog

Joshua Brody: Excited for the CME event on CAR T-cell therapy for lymphoma and CLL at SOHO2024

Joshua Brody shared on LinkedIn: "Excited for the Amps-to-go-up-to-11 at tomorrow's CME event on CAR…

Sep 4, 2024, 15:31 | Blog

The unique challenges many men face during their cancer journey - Paxman Scalp Cooling

Paxman Scalp Cooling shared a post on LinkedIn: ''Prostate Cancer Awareness Month reminds us of…

Sep 4, 2024, 05:14 | Blog

Chromatin and Cancer: From Mechanisms to Emerging Therapies with Charles Roberts - AIEOP

AIEOP (Italian Association of Pediatric Hematology Oncology) shared a post by St. Jude Children's Research…

Sep 3, 2024, 16:13 | Blog

Rami Manochakian: Educational event during WCLC24 on latest advancements in lung cancer

Rami Manochakian shared on X: “Excited to join the Oncology Brothers, great colleagues & experts,…

Sep 3, 2024, 15:07 | Blog

Aaron Walton: Together, we can help more kids enjoy a bright future

Aaron Walton, Division Administrator at The University of Texas MD Anderson Cancer Center, Division of…

Sep 2, 2024, 18:35 | Blog

Dr. Owen O'Connor: The Vessel of Hope for Peripheral T-Cell Lymphoma Braves the Storm and Forges Ahead Fearlessly

MediaMedic made the following blog on LinkedIn: "In order to further improve the diagnostic and treatment…

Sep 2, 2024, 15:41 | Blog

NCI is seeking information for cancer prevention, treatment, and survivorship

NCI Division of Cancer Control and Population Sciences shared a post on LinkedIn: "Deadline extended…

Sep 2, 2024, 15:20 | Blog

Rajesh Rai: Cutting-edge app designed to simplify your access to the latest drugs, research, and critical information needed for effective cancer treatment

Rajesh Rai, Co-Founder of Oncowise AI, shared on LinkedIn: “Hi Oncology Friends, We're thrilled to…

Sep 2, 2024, 10:54 | Opinion

David Fajgenbaum: It's a common misconception that approval marks the peak of a drug's journey

David Fajgenbaum shared on X: “When a drug receives FDA approval, its research and development…

Sep 2, 2024, 10:12 | Blog

Kelly Anderson: Gut microbiome and cancer outcomes holds great potential for future research and treatments

Kelly Anderson, Healthcare Expert, shared the following post by MD Anderson Cancer Center on X, adding…

Sep 2, 2024, 09:38 | Insight

Antonio Passaro: EMA approves amivantamab in combination with chemo for treatment of advanced EGFR-mutated NSCLC after Osimertinib

Antonio Passaro, shared a post on X: "EMA approves amivantamab in combination with chemo for…

Sep 2, 2024, 09:12 | Insight

George Pentheroudakis: We propose a research and regulatory framework for validation/graduation of tumour-agnostic therapies and biomarkers

George Pentheroudakis, Chief Medical Officer at ESMO, shared the following post by Vivek Subbiah on…

Sep 2, 2024, 08:40 | Blog

David Braun: We can make a personalized vaccine to target those tumor-specific antigens

Dana-Farber Cancer Institute shared a post on X: “'If we can identify neoantigens specific to…

Sep 1, 2024, 17:03 | Blog

Vivek Subbiah: Our WHY is YOU!

Vivek Subbiah shared a post on LinkedIn: ''Clinical trials, Drug development unit dream team. Yes!…

Sep 1, 2024, 16:52 | Blog

Paolo Cotzia about the ESMO Tumor-Agnostic Classifier taxonomy

Paolo Cotzia shared a post on LinkedIn about recently published paper: The ESMO Tumour-Agnostic Classifier…

Sep 1, 2024, 16:37 | Blog

Advancements in Medical Treatments, Neuroscience, and the Power of Metals - The Babak Lab

The Babak Lab shared a post on LinkedIn: ''Weekly Digest: Advancements in Medical Treatments, Neuroscience,…

Sep 1, 2024, 16:31 | Blog

Celebrating 25 years of excellence in Gamma Knife radiosurgery at Atrium Health

Atrium Health shared a post on LinkedIn: ''We're going to party like it's 1999! That's…

Sep 1, 2024, 16:26 | Blog

Vivek Subbiah: Clinical trial vs fiction

Vivek Subbiah shared an article on LinkedIn: ''Every single drug, medicine, and treatment you’ve ever…

Sep 1, 2024, 16:18 | Blog

Miriam Mutebi has been featured in the 2024 edition of ‘100 Influential Women in Oncology’ by OncoDaily - Aga Khan University

Aga Khan University shared a post on X: ''Proud Moment! AKU's Dr Miriam Mutebi has…

Sep 1, 2024, 12:16 | Blog

Peter Pisters: The end of an exceptional fiscal year at MD Anderson Cancer Center

Peter Pisters shared a post on LinkedIn: ''This week marks the end of an exceptional…

Sep 1, 2024, 09:14 | Insight

Power Of Metals Gold, Silver, and Copper in Our Daily Lives and Cancer Treatment - The Babak Lab

Maria Babak shared a post by The Babak Lab on LinkedIn, adding: "The Babak Lab is going…

Aug 31, 2024, 10:53 | Blog

OncoInfluencers to Follow on Social Media: Dr. Fabio Ynoe de Moraes

We are excited to feature Dr. Fabio Ynoe de Moraes, a distinguished expert in radiation…

Aug 27, 2024, 21:44 | Blog

Advancing the field of Cancer Immunotherapy - National Foundation for Cancer Research

National Foundation for Cancer Research made the following post on X: "At National Foundation for Cancer…

Aug 26, 2024, 21:39 | Blog

Article of the day suggested by the Immune Oncology Research Institute

Immune Oncology Research Institute made the following post on LinkedIn: "Article of the day suggested…